For patients, this research could lead to new treatments that protect the insulin-producing cells ... would allow doctors to directly target beta cell loss, which could improve long-term disease ...

Researchers have discovered a novel approach to protecting insulin-producing beta cells ... this approach would allow doctors to directly target beta cell loss, which could improve long-term ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

In a revolutionary medical procedure, insulin-producing cells derived from a young woman’s own body were successfully ...

They also affect insulin-mediated regulation of endothelial cell function. In addition, several reports indicate that the effects of all three polymorphisms on the risk of T2DM and cardiovascular ...

Conditionally immortalized human glomerular endothelial cells do not respond to insulin, suggesting that insulin has a specific effect on the podocyte in the glomerular filtration barrier.

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Here, Cho et al. show in human umbilical venous endothelial cells that the peptide hormone adrenomedullin inhibits insulin signalling, via binding to adrenomedullin receptors on endothelial cells ...

Hormones are released from endocrine glands and are transported in the blood to target cells Insulin: released from pancreas, stimulates liver cells to take up glucose from the blood and Glucagon ...

When this gene was knocked out in beta cells from people with type 2 diabetes, the researchers found an increased release of insulin. The results suggest that IGFBP7 may be a drug target for type ...